Skip to main content
PMC home page
Molecular Medicine logoLink to Molecular Medicine
. 1998 Nov;4(11):700–706.

Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene.

R D Simari 1, Z Y Yang 1, X Ling 1, D Stephan 1, N D Perkins 1, G J Nabel 1, E G Nabel 1
PMCID: PMC2230344  PMID: 9932107

Abstract

BACKGROUND: The cytomegalovirus immediate early (CMV IE) promoter has been widely used for heterologous expression. Further enhancements of gene expression from this potent promoter may allow for the development of improved gene transfer strategies. We aimed to determine whether inclusion of the first exon (5' untranslated) and first intron of the CMV IE gene would increase heterologous transgene expression in primary target cells and to determine the sequences required for any observed increases. MATERIALS AND METHODS: Comparisons of reporter gene expression were made following transient transfection of vascular smooth muscle cells (VSMCs) with plasmids containing the first exon and intron from the CMV IE gene or deletional mutations. Comparisons were also made using a heterologous promoter (RSV). RESULTS: Gene expression from the CMV IE promoter was increased 5.7-fold in VSMC with the inclusion of the first exon and intron. Similar increases were seen with other target cells and from the heterologous RSV promoter. This increase was associated with an increase in steady-state mRNA. Deletion analyses demonstrated that the enhancement was dependent on the presence of the 5' portion of the first exon while deletion of large segments within the intron was associated with similar levels of expression compared with the parental plasmid. CONCLUSIONS: Inclusion of the first exon and intron from the CMV IE gene increases expression from the CMV IE promoter. This enhancement is seen with the heterologous RSV promoter and is associated with an increase in steady-state mRNA. Deletion analyses suggest that this enhancement is associated with inclusion of sequences within the 5' portion of the first exon and inclusion of an intron.

Full text

PDF
700

Images in this article

701Fig. 1
on p.701
703Fig. 3
on p.703

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchman A. R., Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol. 1988 Oct;8(10):4395–4405. doi: 10.1128/mcb.8.10.4395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chapman B. S., Thayer R. M., Vincent K. A., Haigwood N. L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 1991 Jul 25;19(14):3979–3986. doi: 10.1093/nar/19.14.3979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chapman G. D., Lim C. S., Gammon R. S., Culp S. C., Desper J. S., Bauman R. P., Swain J. L., Stack R. S. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res. 1992 Jul;71(1):27–33. doi: 10.1161/01.res.71.1.27. [DOI] [PubMed] [Google Scholar]
  4. Choi T., Huang M., Gorman C., Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol. 1991 Jun;11(6):3070–3074. doi: 10.1128/mcb.11.6.3070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooper M. J., Miron S. Efficient episomal expression vector for human transitional carcinoma cells. Hum Gene Ther. 1993 Oct;4(5):557–566. doi: 10.1089/hum.1993.4.5-557. [DOI] [PubMed] [Google Scholar]
  6. Ghazal P., Lubon H., Fleckenstein B., Hennighausen L. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3658–3662. doi: 10.1073/pnas.84.11.3658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ghazal P., Nelson J. A. Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter. J Virol. 1991 May;65(5):2299–2307. doi: 10.1128/jvi.65.5.2299-2307.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leclerc G., Gal D., Takeshita S., Nikol S., Weir L., Isner J. M. Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest. 1992 Sep;90(3):936–944. doi: 10.1172/JCI115970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Muller D. W., Gordon D., San H., Yang Z., Pompili V. J., Nabel G. J., Nabel E. G. Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res. 1994 Dec;75(6):1039–1049. doi: 10.1161/01.res.75.6.1039. [DOI] [PubMed] [Google Scholar]
  11. Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14;249(4974):1285–1288. doi: 10.1126/science.2119055. [DOI] [PubMed] [Google Scholar]
  12. Nabel E. G., Plautz G., Nabel G. J. Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5157–5161. doi: 10.1073/pnas.89.11.5157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nabel G. J., Nabel E. G., Yang Z. Y., Fox B. A., Plautz G. E., Gao X., Huang L., Shu S., Gordon D., Chang A. E. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307–11311. doi: 10.1073/pnas.90.23.11307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Niwa M., Rose S. D., Berget S. M. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 1990 Sep;4(9):1552–1559. doi: 10.1101/gad.4.9.1552. [DOI] [PubMed] [Google Scholar]
  15. Palmiter R. D., Sandgren E. P., Avarbock M. R., Allen D. D., Brinster R. L. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):478–482. doi: 10.1073/pnas.88.2.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. San H., Yang Z. Y., Pompili V. J., Jaffe M. L., Plautz G. E., Xu L., Felgner J. H., Wheeler C. J., Felgner P. L., Gao X. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther. 1993 Dec;4(6):781–788. doi: 10.1089/hum.1993.4.6-781. [DOI] [PubMed] [Google Scholar]
  17. Schmidt E. V., Christoph G., Zeller R., Leder P. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol. 1990 Aug;10(8):4406–4411. doi: 10.1128/mcb.10.8.4406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Simari R. D., San H., Rekhter M., Ohno T., Gordon D., Nabel G. J., Nabel E. G. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest. 1996 Jul 1;98(1):225–235. doi: 10.1172/JCI118770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stephan D. J., Yang Z. Y., San H., Simari R. D., Wheeler C. J., Felgner P. L., Gordon D., Nabel G. J., Nabel E. G. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther. 1996 Oct 1;7(15):1803–1812. doi: 10.1089/hum.1996.7.15-1803. [DOI] [PubMed] [Google Scholar]
  20. Stewart M. J., Plautz G. E., Del Buono L., Yang Z. Y., Xu L., Gao X., Huang L., Nabel E. G., Nabel G. J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther. 1992 Jun;3(3):267–275. doi: 10.1089/hum.1992.3.3-267. [DOI] [PubMed] [Google Scholar]
  21. Takeshita S., Gal D., Leclerc G., Pickering J. G., Riessen R., Weir L., Isner J. M. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest. 1994 Feb;93(2):652–661. doi: 10.1172/JCI117017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wheeler C. J., Felgner P. L., Tsai Y. J., Marshall J., Sukhu L., Doh S. G., Hartikka J., Nietupski J., Manthorpe M., Nichols M. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11454–11459. doi: 10.1073/pnas.93.21.11454. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES